enoxacin has been researched along with Chlamydia Infections in 3 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
Chlamydia Infections: Infections with bacteria of the genus CHLAMYDIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Enoxacin (ENX) is a new derivative of pyridonecarboxylic acid and has a broad spectrum antibacterial activity." | 5.27 | [Clinical experience of enoxacin in the treatment of nongonococcal urethritis]. ( Fujioka, H; Ichikawa, Y; Ishibashi, M; Matsuda, M; Matsui, T; Nakano, E; Okuyama, A; Sonoda, T; Takaha, M, 1987) |
| "The results of two therapeutic trials in female patients with uncomplicated urogenital gonorrhoea (A) and in male patients with uncomplicated urethral gonorrhoea (B) treated with either 200 mg and 400 mg enoxacin orally, of one therapeutic trial in male patients with uncomplicated urogenital gonorrhoea treated with either 250 mg or 500 mg ciprofloxacin orally (C) and of one therapeutic trial in male patients with non-gonococcal urethritis (NGU) treated with ciprofloxacin 1 g daily during seven days (D) are presented and compared with the results of other investigators." | 5.06 | Quinolones in the treatment of gonorrhoea and Chlamydia trachomatis infections. ( Stolz, E; van der Willigen, AH; Wagenvoort, JH, 1987) |
| "Enoxacin (ENX) is a new derivative of pyridonecarboxylic acid and has a broad spectrum antibacterial activity." | 1.27 | [Clinical experience of enoxacin in the treatment of nongonococcal urethritis]. ( Fujioka, H; Ichikawa, Y; Ishibashi, M; Matsuda, M; Matsui, T; Nakano, E; Okuyama, A; Sonoda, T; Takaha, M, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chidiac, C | 1 |
| Senneville, E | 1 |
| Mouton, Y | 1 |
| Stolz, E | 1 |
| Wagenvoort, JH | 1 |
| van der Willigen, AH | 1 |
| Nakano, E | 1 |
| Ichikawa, Y | 1 |
| Ishibashi, M | 1 |
| Okuyama, A | 1 |
| Matsuda, M | 1 |
| Takaha, M | 1 |
| Sonoda, T | 1 |
| Fujioka, H | 1 |
| Matsui, T | 1 |
1 review available for enoxacin and Chlamydia Infections
| Article | Year |
|---|---|
[Value of quinolones in the treatment of lower respiratory tract infections caused by intracellular organisms, excluding mycobacteria].
Topics: Anti-Infective Agents; Chlamydia Infections; Ciprofloxacin; Enoxacin; Erythromycin; Humans; In Vitro | 1992 |
1 trial available for enoxacin and Chlamydia Infections
| Article | Year |
|---|---|
Quinolones in the treatment of gonorrhoea and Chlamydia trachomatis infections.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Chlamydia Infections; Chlamydia trachomatis | 1987 |
1 other study available for enoxacin and Chlamydia Infections
| Article | Year |
|---|---|
[Clinical experience of enoxacin in the treatment of nongonococcal urethritis].
Topics: Adolescent; Adult; Anti-Infective Agents, Urinary; Chlamydia Infections; Chlamydia trachomatis; Enox | 1987 |